Author:
Wang Chengfang,Wu Yingsheng,Wang Weilin
Publisher
Ovid Technologies (Wolters Kluwer Health)
Subject
Endocrinology,Hepatology,Endocrinology, Diabetes and Metabolism
Reference86 articles.
1. Cancer statistics, 2021.;Siegel;CA Cancer J Clin,2021
2. Current strategies for detection and treatment of recurrence of pancreatic ductal adenocarcinoma after resection.;Groot;Pancreas,2017
3. Comparison of adjuvant gemcitabine and capecitabine with gemcitabine monotherapy in patients with resected pancreatic cancer (ESPAC-4): a multicentre, open-label, randomised, phase 3 trial.;Neoptolemos;Lancet,2017
4. FOLFIRINOX or gemcitabine as adjuvant therapy for pancreatic cancer.;Conroy;N Engl J Med,2018
5. Resected adenocarcinoma of the pancreas-616 patients: results, outcomes, and prognostic indicators.;Sohn;J Gastrointest Surg,2000
Cited by
3 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献